Skip to main content
Fig. 3 | Critical Care

Fig. 3

From: The impact of higher protein dosing on outcomes in critically ill patients with acute kidney injury: a post hoc analysis of the EFFORT protein trial

Fig. 3

A Subgroup analysis for TTDA in patients with AKI. B Subgroup analysis for 60-day mortality in patients with AKI. p-value: interaction between the subgroups. AKI: Acute kidney injury, APACHE II score: the acute physiology and chronic health evaluation II score, BMI: body mass index, CI: confidence interval, Frailty: measured using the clinical frailty scale, HR: Hazard ratio, KRT: kidney replacement therapy, mNUTRIC: the nutrition risk in critically ill score, SARC-F: a questionnaire to measure risk of sarcopenia, SOFA: sequential organ failure assessment, TTDA: time-to-discharge alive from the hospital. Note: Received versus not received KRT—patients who received or not received KRT post randomization. Ever versus never dialyzed—patients who ever or never dialyzed prior to or during the current ICU stay

Back to article page

Critical Care

ISSN: 1364-8535